Pardes Habib1, Ann-Sophie Stamm2, Thomas Zeyen2, Rozina Noristani2, Alexander Slowik3, Cordian Beyer3, Thomas Wilhelm4, Michael Huber4, Daniel Komnig2, Jörg B Schulz5, Arno Reich2. 1. Department of Neurology, Medical School, RWTH Aachen University, Aachen, Germany. Electronic address: phabib@ukaachen.de. 2. Department of Neurology, Medical School, RWTH Aachen University, Aachen, Germany. 3. Institute of Neuroanatomy, Medical School, RWTH Aachen University, Aachen, Germany. 4. Institute of Biochemistry and Molecular Immunology, Medical School, RWTH Aachen University, Aachen, Germany. 5. Department of Neurology, Medical School, RWTH Aachen University, Aachen, Germany; JARA-BRAIN Institute of Molecular Neuroscience and Neuroimaging, Forschungszentrum Jülich GmbH and RWTH Aachen University, Aachen, Germany.
Abstract
BACKGROUND AND PURPOSE: Transmembrane BAX Inhibitor-1 Motif-containing (TMBIM) family members exert inhibitory activities in apoptosis and necroptosis. FAIM2 (TMBIM-2) is neuroprotective against murine focal ischemia and is regulated by erythropoietin (EPO). Similar to FAIM2, GRINA (TMBIM-3) is predominantly expressed in the brain. The role of GRINA in transient brain ischemia, its potential synergistic effects with FAIM2 and its regulation by EPO treatment were assessed. METHODS: We performed transient (30 min) middle cerebral artery occlusion (tMCAo) followed by 72 h of reperfusion in GRINA-deficient (GRINA-/-), FAIM2-deficient (FAIM2-/-), double-deficient (GRINA-/-FAIM2-/-) and wildtype littermates (WT) mice. We administered EPO or saline 0, 24 and 48 h after tMCAo. We subjected primary murine cortical neurons (pMCN) of all mouse strains to oxygen-glucose deprivation (OGD) after GRINA and/or FAIM2 gene transfection. RESULTS: Compared to wildtype controls GRINA deficiency led to a similar increase in infarct volumes as FAIM2 deficiency (p < .01). We observed the highest neurological deficits and largest infarct sizes in double-deficient mice. EPO administration upregulated GRINA and FAIM2 mRNA levels in wildtype littermates. EPO decreased infarct sizes and abrogated neurological impairments in wildtype controls. GRINA and/or FAIM2 deficient mice showed increased expression levels of cleaved-caspase 3 and of pro-apoptotic BAX mRNA. Further, caspase 8 was upregulated in FAIM2-/- and caspase 9 in GRINA-/- mice. Overexpression of GRINA and FAIM2 in wildtype and in double deficient pMCN decreased cell death rate after OGD. CONCLUSIONS: GRINA and FAIM2 are highly expressed in the brain and convey EPO-mediated neuroprotection after ischemic stroke involving different caspases.
BACKGROUND AND PURPOSE: Transmembrane BAX Inhibitor-1 Motif-containing (TMBIM) family members exert inhibitory activities in apoptosis and necroptosis. FAIM2 (TMBIM-2) is neuroprotective against murine focal ischemia and is regulated by erythropoietin (EPO). Similar to FAIM2, GRINA (TMBIM-3) is predominantly expressed in the brain. The role of GRINA in transient brain ischemia, its potential synergistic effects with FAIM2 and its regulation by EPO treatment were assessed. METHODS: We performed transient (30 min) middle cerebral artery occlusion (tMCAo) followed by 72 h of reperfusion in GRINA-deficient (GRINA-/-), FAIM2-deficient (FAIM2-/-), double-deficient (GRINA-/-FAIM2-/-) and wildtype littermates (WT) mice. We administered EPO or saline 0, 24 and 48 h after tMCAo. We subjected primary murine cortical neurons (pMCN) of all mouse strains to oxygen-glucose deprivation (OGD) after GRINA and/or FAIM2 gene transfection. RESULTS: Compared to wildtype controls GRINA deficiency led to a similar increase in infarct volumes as FAIM2 deficiency (p < .01). We observed the highest neurological deficits and largest infarct sizes in double-deficient mice. EPO administration upregulated GRINA and FAIM2 mRNA levels in wildtype littermates. EPO decreased infarct sizes and abrogated neurological impairments in wildtype controls. GRINA and/or FAIM2 deficient mice showed increased expression levels of cleaved-caspase 3 and of pro-apoptotic BAX mRNA. Further, caspase 8 was upregulated in FAIM2-/- and caspase 9 in GRINA-/- mice. Overexpression of GRINA and FAIM2 in wildtype and in double deficient pMCN decreased cell death rate after OGD. CONCLUSIONS:GRINA and FAIM2 are highly expressed in the brain and convey EPO-mediated neuroprotection after ischemic stroke involving different caspases.
Authors: Nina Hahn; Luca Büschgens; Nicola Schwedhelm-Domeyer; Sarah Bank; Bart R H Geurten; Pia Neugebauer; Bita Massih; Martin C Göpfert; Ralf Heinrich Journal: Front Mol Neurosci Date: 2019-10-11 Impact factor: 5.639
Authors: Eren Arik; Ole Heinisch; Michaela Bienert; Lara Gubeljak; Alexander Slowik; Arno Reich; Jörg B Schulz; Thomas Wilhelm; Michael Huber; Pardes Habib Journal: Front Cell Neurosci Date: 2022-06-24 Impact factor: 6.147
Authors: Thomas Zeyen; Rozina Noristani; Shahin Habib; Ole Heinisch; Alexander Slowik; Michael Huber; Jörg B Schulz; Arno Reich; Pardes Habib Journal: J Mol Med (Berl) Date: 2020-05-07 Impact factor: 4.599
Authors: Pardes Habib; Ann-Sophie Stamm; Joerg B Schulz; Arno Reich; Alexander Slowik; Sandro Capellmann; Michael Huber; Thomas Wilhelm Journal: Int J Mol Sci Date: 2019-10-31 Impact factor: 5.923
Authors: Alma Kokott-Vuong; Jennifer Jung; Aaron T Fehr; Nele Kirschfink; Rozina Noristani; Aaron Voigt; Arno Reich; Jörg B Schulz; Michael Huber; Pardes Habib Journal: Int J Mol Sci Date: 2021-10-28 Impact factor: 5.923
Authors: Ole Heinisch; Thomas Zeyen; Tobias Goldmann; Marco Prinz; Michael Huber; Jennifer Jung; Eren Arik; Shahin Habib; Alexander Slowik; Arno Reich; Jörg B Schulz; Pardes Habib Journal: Transl Stroke Res Date: 2021-10-09 Impact factor: 6.800